PRCSR CRISPR: Vivlion's CRISPR-enabled Discovery Platform | CRISPR-based Genetic Screens Enable the Discovery of Oncology Drug Targets, Predictive Biomarkers, and Mechanisms of Resistance
- Nov. 28, 2023
CMN Webinar | Wednesday December 6, 2023 | 3:00 pm–4:30 pm CET / 9:00 am–10:30 am EDT
PRCSR CRISPR: Vivlion's CRISPR-enabled Discovery Platform | CRISPR-based Genetic Screens Enable the Discovery of Oncology Drug Targets, Predictive Biomarkers, and Mechanisms of Resistance
Read more here
